Apellis pharmaceuticals announces inducement grants under nasdaq listing rule 5635(c)(4)

Waltham mass., dec. 06, 2024 (globe newswire) -- apellis pharmaceuticals, inc. (nasdaq: apls), a global biopharmaceutical company and leader in complement, today announced that the company approved the grant of equity awards to four new employees with a grant date of december 2, 2024, as equity inducement awards outside of the company's 2017 stock incentive plan (but under the terms of the 2020 inducement stock incentive plan) and material to the employees' acceptance of employment with the company. the equity awards were approved in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking